Author

Rachel L. Manthe

Observed names: Manthe, Rachel Lee, Rachel Manthe

Institutions: American Society For Engineering Education, Institute for Bioscience and Biotechnology Research, University of Maryland, College Park

Observed institutions: University of Akron, American Society For Engineering Education, Institució Catalana de Recerca i Estudis Avançats, United States Naval Research Laboratory, National Institutes of Health, Cleveland Clinic, Barcelona Institute of Science and Technology, Institute for Bioengineering of Catalonia, National Center for Advancing Translational Sciences, Naval Research Laboratory Center for Bio/Molecular Science and Engineering, Institute for Bioscience and Biotechnology Research, Cleveland Clinic Research, University of Maryland, College Park

OpenAlex ID: A5023336533

Optical Imaging and Magnetic Field Targeting of Magnetic Nanoparticles in Tumors

2010 · Susan P. Foy, Rachel L. Manthe, et al. · ACS Nano · 149

Tumor Ablation and Nanotechnology

2010 · Rachel L. Manthe, Susan P. Foy, et al. · Molecular Pharmaceutics · 136

Active cellular sensing with quantum dots: Transitioning from research tool to reality; a review

2012 · James B. Delehanty, Kimihiro Susumu, et al. · Analytica Chimica Acta · 77

Electrospinning of l-tyrosine polyurethanes for potential biomedical applications

2009 · Parth N. Shah, Rachel L. Manthe, et al. · Polymer · 54

A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders

2015 · Jeff Rappaport, Rachel L. Manthe, et al. · Molecular Pharmaceutics · 41

Synthesizing and Modifying Peptides for Chemoselective Ligation and Assembly into Quantum Dot-Peptide Bioconjugates

2013 · W. Russ Algar, Juan B. Blanco-Canosa, et al. · Methods in molecular biology · 32

ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator

2016 · Rachel L. Manthe, Silvia Muro · Bioengineering & Translational Medicine · 29

Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme

2020 · Rachel L. Manthe, Maximilian Loeck, et al. · Journal of Controlled Release · 26

How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers

2016 · Daniel Serrano, Rachel L. Manthe, et al. · Biomacromolecules · 24

Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery

2015 · Jeff Rappaport, Rachel L. Manthe, et al. · Molecular Pharmaceutics · 19

δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?

2019 · Rachel L. Manthe, Jeffrey A. Rappaport, et al. · Journal of Pharmacology and Experimental Therapeutics · 6

Lysosomes and Nanotherapeutics: Diseases, Treatments, and Side Effects

2014 · Rachel L. Manthe, Silvia Muro · Frontiers in nanobiomedical research · 2

Development of a design- and project-based framework to include scientific reasoning in an undergraduate, introductory-level bioengineering laboratory course

2020 · Idalis Villanueva, Rachel Manthe, et al. · ASEE Annual Conference & Exposition · 1

Investigation of Vesicular-Mediated Transport of Intercellular Adhesion Molecule-1-Targeted Carriers for Treatment of Lysosomal Storage Disorders

2017 · Manthe, Rachel Lee · University Libraries (University of Maryland)

Enhanced lysosomal enzyme delivery across the blood-brain barrier by modulating the valency of ICAM-1-targeted nanocarriers

2016 · Rachel L. Manthe, Edward H. Schuchman, et al. · Molecular Genetics and Metabolism

Works count: 15

Citation count: 596

H-index: 10

I10-index: 10